CAR T treatments in Sweden

SWECARNET collects information direct from treating clinicians to map the use of CAR T in Sweden.

The first CAR T to be manufactured in Sweden (and Europe) was in 2014 at Vecura, Stockholm, and was used for academic clinical trial in Uppsala. The first Standard of Care use of a commercial CAR T was in November 2019 at Karolinska University Hospital. There are now several treatment centres in Sweden and several products have been administered in clinical trial and/or standard of care.

SWECARNET collects information direct from treating clinicians to map the use of CAR T in Sweden. We will endeavour to keep this page as up to date as possible. If you would like a more recent version or more specific information, please feel free to make contact with Hanna Sjölund (SWECARNET coordinator).

Swedish CAR T/TCR treatments

A map that shows the Swedish CAR T treatments. Also described in text below the picture.


The picture in text:

Data from SWECARNET 2024, updated March 6, 2025 

  • Now: 261 patients.
  • Currently treated nationally; 267 infusions (6 RI) – 13 children.

Abbreviations:

  • SOC = Standard of Care - SOC.
  • ACT = Academic Clinical Trial - ACT.
  • ICT = Industry Clinical Trial - ICT.
  • GMP = GMP manufacture.
  • RI = Reinfusion.

Umeå (9 infusions):

  • First SOC Dec 2023 – Now 9 patients.

Uppsala (77 infusions):

  • Academic trial 3rd generation CAR T since 2014.
  • First ACT 2014 – Now 42 patients.
  • First SOC Nov 2020 – Now 33 patients.
  • First ICT June 2023 – Now 2 patients.

Stockholm (81 infusions):

  • Manufacture 3rd generation CAR T since 2014 – Karolinska/Vecura – 39 GMP batches.
  • First ICT Aug 2019 – Now 15 patients.
  • First SOC Nov 2019 – Now 61 patients, 5 RI.

Örebro:

  • Upcoming treatment center.

Linköping (20 infusions):

  • First SOC Jan 2020 – Now 18 patients.
  • First ICT Apr 2023 – Now 2 patients.

Gothenburg (27 infusions):

  • First SOC Oct 2020 – Now 23 patients.
  • First ICT Oct 2022 – Now 2 patient, 1 RI.
  • First CUP Feb 2024 – Now 1 patient.

Lund (53 infusions):

  • First SOC Jan 2020 – Now 48 patients.
  • First ICT Nov 2021 – Now 5 patients.